Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of Crohn's disease-associated refractory diarrhoea with octreotide LAR
2010-023347-14Phase 2Completed
- Sponsor
- Groupe santé CHC
- Start
- Jan 2011
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of octreotide in Crohn's disease and diarrhea, sponsored by Groupe santé CHC. Primary endpoint: Effect of octreotide on Crohn's disease-associated diarrhoea. Started Jan 2011; status: completed.
02
Drugs
octreotide
03
Conditions
Crohn's diseasediarrhea
Beyond the preview
Go deeper on 2010-023347-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023347-14.